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Abstract 
An origin activation checkpoint has recently been discovered in the G1 phase of the mitotic 
cell cycle, which can be triggered by loss of DNA replication initiation factors such as the 
Cdc7 kinase.  Insufficient levels of Cdc7 activate cell cycle arrest in normal cells, whereas 
cancer cells appear to lack this checkpoint response, do not arrest and proceed with an 
abortive S phase, leading to cell death.  The differential response between normal and 
tumour cells at this checkpoint has led to widespread interest in the development of 
pharmacological Cdc7 inhibitors as novel anti-cancer agents.  We have used RNAi against 
Cdc7 in combination with SILAC-based high resolution MS proteomics to investigate the 
cellular mechanisms underlying the maintenance of the origin activation checkpoint in 
normal human diploid fibroblasts.  Bioinformatics analysis identified clear changes in wide-
ranging biological processes including altered cellular energetic flux, moderate stress 
response, reduced proliferative capacity and a spatially-distributed response across the 
mitochondria, lysosomes and the cell surface.  These results provide a quantitative overview 
of the processes involved in maintenance of the arrested state, show that this phenotype 
involves active rather than passive cellular adaptation, and highlight a diverse set of proteins 
responsible for cell cycle arrest and ultimately for promotion of cellular survival.  We propose 
that the Cdc7-depleted proteome maintains cellular arrest by initiating a dynamic 
quiescence-like response, and that the complexities of this phenotype will have important 
implications for the continued development of promising Cdc7-targeted cancer therapies. 
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Introduction 
The DNA replication licensing process of the mitotic cell cycle is stringently and precisely 
regulated to ensure correct duplication of the eukaryotic genome only once per cell cycle 1-3.  
During early G1 phase, origin “licensing” occurs at thousands of replication origins 
distributed along human chromosomes and is a pre-requisite for the initiation of DNA 
replication.  The origin recognition complex (ORC) binds to DNA at these sites and recruits 
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Cdc6 and Cdt1, which in turn load the minichromosome maintenance replicative helicase 
(MCM2-7) onto DNA.  Together this assembly is termed the pre-replicative complex (pre-
RC).  Origin activation occurs in late G1 phase and involves phosphorylation of the pre-RC 
constituents by at least two protein kinases, CDK (cyclin-dependent kinases) and the 
Cdc7/ASK kinase.  This leads to local unwinding of the double-stranded DNA, loading of the 
replisome (composed of DNA polymerases and auxiliary factors) and progression into S 
phase for DNA synthesis and chain elongation 1-3.  To avoid re-duplication of the genome 
and potentially cancer-causing defects, the DNA replication process is strictly monitored by 
cell cycle checkpoints and by mechanisms which prevent the formation of pre-RCs during 
the S, G2 and M phases of the cell cycle.   
 
The highly conserved Cdc7 kinase plays a critical role in the DNA replication initiation 
pathway by promoting entry into S phase through phosphorylation and activation of the 
MCM2-7 helicase 4-6.  Several other functions have been attributed to the Cdc7 kinase, 
including cohesion loading onto chromatin for chromosomal segregation in mitosis 7, double-
strand break formation during meiotic recombination 8, and activation of the DNA damage 
repair ATR-Chk1 pathway 9, 10.  Recently, targeting of Cdc7 with RNAi or small molecule 
inhibitors has been shown to result in potent cancer-cell-specific-killing in a range of tumour 
types of both epithelial and mesenchymal origin 1, 11-13.  Cancer cells are thought to establish 
only limited numbers of replication forks under Cdc7 rate-limiting conditions, causing fork 
stalling and collapse during an abortive S phase and triggering apoptotic cell death.  The 
specificity of this novel anti-cancer approach is critically dependent on the fact that 
untransformed cells avoid lethal S phase progression in the presence of low Cdc7 kinase 
activity by eliciting a Cdc7 inhibition checkpoint response that arrests cells at the G1/S 
boundary 11, 12, 14.  Our recent studies in normal human diploid fibroblasts have revealed the 
molecular architecture and circuitry involved in this enigmatic  checkpoint response 15.  In 
arrested cells, FoxO3a activates the ARF┤Mdm2┤p53→p21 pathway and mediates p15INK4B 
upregulation.  p53 in turn activates expression of the Wnt/ -catenin signalling antagonist 
Dkk3, leading to Myc and cyclin D1 down-regulation.  The resulting loss of CDK activity 
inactivates the Rb-E2F pathway and overrides the G1-S transcriptional program leading to a 
robust G1/S cell cycle arrest 15.  Notably, this signalling network includes many common 
proto-oncogenes and tumour suppressors which explains why so many tumour types are 
unable to engage a protective G1/S checkpoint response in response to Cdc7 rate-limiting 
conditions.  
 
Currently there is intense interest in the development of pharmacological Cdc7 inhibitors as 
novel anticancer agents 13, 16, 17.  We have recently demonstrated that the cell cycle arrest 
following activation of the Cdc7-inhibition checkpoint in primary somatic cells is fully 
reversible on recovery of Cdc7 kinase activity, and that cells remain viable while arrested at 
the G1-S boundary 12.  However an important and unanswered question relates to how 
primary cells maintain cell viability following activation of the Cdc7-inhibition checkpoint, 
information which is of crucial importance in understanding how human tissues can 
potentially avoid toxicity from Cdc7 inhibitors, and thus reinforcing the specificity of such a 
therapeutic approach.  In this paper we apply a global proteomics approach to quantitatively 
evaluate the cellular-wide response to Cdc7 depletion and to better understand the 
preservation of the checkpoint phenotype in normal cells.  The origin activation checkpoint 
was triggered by RNAi against Cdc7 in IMR90 fibroblasts and a quantitative SILAC 
proteomics strategy with high accuracy LC-MS/MS was applied to this experimental system.   
 
We show that the predominant response to Cdc7 depletion is to actively maintain the cells in 
an arrested state by modulating the cellular metabolic signature, by inducing an oxidative 
stress response to limit cellular damage, and by suppressing RNA stability and protein 
translation.  Our results suggest a spatially-distributed response over different subcellular 
locations including mitochondria, lysosomes and the cell surface.  In short, Cdc7 depletion 
triggers a panel of responses which are similar to those evoked during cellular quiescence 
3 
 
(G0).  Contrary to the widely held assumption that quiescent cells exist in a static and 
passive phase, we support the opinion that G0 is actually a dynamic and highly active 
collection of states responsible for reversible cellular arrest 18.  In addition to well-defined 
cellular pathways and networks, our study reveals a novel role for many proteins that have 
not been previously associated with cell cycle regulation.  This global and quantitative 
proteomics analysis of the Cdc7-depleted cellular environment will provide a valuable 
reference point for ongoing Cdc7-targeted drug development. 
 
Experimental Procedures 
Cell culture and SILAC labelling 
IMR90 (ATCC CCL-186), a human primary diploid fibroblast adherent cell line, was obtained 
from LGC Standards (Middlesex, UK) at population doubling (PD) 12.  All experiments with 
IMR90 cells were performed with a PD of less than 22.  IMR90 cells were cultured at 37°C 
with 5% CO2 in SILAC-specific DMEM media (Invitrogen, Paisley, UK), supplemented with 
10% dialyzed FBS (Invitrogen), 100 U/ml penicillin and 100 g/ml streptomycin (Sigma 
Aldrich, Poole, UK) according to manufacturer’s instructions (Invitrogen, Paisley, UK).  For 
quantitative SILAC analysis of two labelling states, the cells were divided into two 
populations, labelled with either “light” L-Lysine and L-Arginine (Lys0, Arg0) or “heavy” 13C6-
Lysine and 13C6,15N4-Arginine (Lys6, Arg10) (Invitrogen, Paisley, UK) and cultured for six 
passages to achieve full incorporation of the SILAC amino acids.   
 
RNA interference 
Small interfering RNA (siRNA) depletion of Cdc7 was performed on the “light” population, 
while the “heavy” cells were transfected with a control oligo for three biological replicates.  
One reverse labelling experiment was performed.  Cdc7 expression was inhibited in SILAC-
labelled IMR90 cells with custom double-stranded RNA oligonucleotides (Ambion, 
Warrington, UK) at 10 nM concentration for 72 hours (5’→3’ sense oligo: 
GCUCAGCAGGAAAGGUGUUUU; antisense oligo: AACACCUUUCCUGCUGAGCUU).  
The Cdc7 siRNA used in this study has previously been extensively characterized for 
transfection efficiency, off-target effects, BrdU incorporation assays and flow cytometry 
studies 11, 15.  Non-targeting siRNA was used as the negative control.  For the rescue 
experiment, the full 1725 bp CDC7 cDNA sequence containing four silent, single base pair 
mutations in the 21 bp Cdc7-siRNA interaction region was inserted into a pCMV6-AC 
expression vector (OriGene) to fully abolish the siRNA effect. 
 
Cell population growth assessment, cell cycle analysis and immunofluorescence 
Phase contrast microscopy was performed with an inverted Axiovert 200M (Carl Zeiss, 
Welwyn Garden City, UK) and Axiovision software.  Flow cytometric cell cycle analysis was 
performed as described previously 19.  For detection of BrdU incorporation, cells were pulsed 
with 100 M BrdU (2 hr), fixed in 3.7% paraformaldehyde (5 min) and permeabilized with 
0.2% Triton X-100 (5 min).  Coverslips were incubated with 2 N HCl (1 hr), washed with PBS 
and incubated with primary anti-BrdU antibody (Alexis Biochemicals, Exeter, UK), 50 ng / ml 
propidium iodide and 50 ng / ml RNase A for 1 hr at 37°C.  Slides were mounted in 
Vectashield mounting medium (Vector Laboratories, Peterborough, UK).  DNA was 
visualized with 1.5 μg / ml DAPI.  Fluorescence confocal microscopy of random fields of cells 
was performed on a Leica TCS SP confocal microscope (Leica, Milton Keynes, UK).  At 
least 400 cells were scored for BrdU incorporation and quantified as percentages of the total 
number of cells. 
 
Sample Preparation, Protein Separation, Immunoblotting and In-Gel Digestion 
Crude nuclear extracts and cytoplasmic fractions were prepared by lysing cells in buffer 
containing 10 mM HEPES pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% 
glycerol, 0.1% Triton X-100, 1 mM DTT and protease inhibitors.  Nuclei were precipitated by 
centrifuging at 1,000 x g for 5 min at 4C and the cytoplasmic fraction was collected.  
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Nuclear pellets were washed with the same buffer, lysed in modified RIPA buffer (50 mM 
Tris-HCl pH 7.4, 300 mM NaCl, 1% sodium deoxycholate, 1% NP-40, 1 mM EDTA, 0.1% 
SDS) for 30 min, sonicated and centrifuged at 13,000 x g. 
 
SILAC analysis was performed on whole cell extracts, where SILAC-labelled cells were 
harvested and lysed for 45 min in ice-cold modified RIPA buffer supplemented with protease 
and phosphatase inhibitors (Roche Diagnostics, Lewes, UK).  Lysates were sonicated on ice 
and centrifuged at 14,000 x g, 4°C for 20 min.  Protein concentration was evaluated by the 
Bio-Rad protein assay kit (Bio-Rad, Hemel Hempstead, UK).  For western blot analysis, 60 
g of total protein was loaded in each lane and separated by 4% to 20% SDS-PAGE.  
Proteins were transferred onto PVDF membranes (Bio-Rad) by semi-dry electroblotting.  
Blocking, antibody incubations and washing steps were performed as described 20.  
Antibodies used: Cdc7 (MBL International, Woburn, MA), Mcm2 and Orc4 (BD Biosciences, 
Oxford, UK), Mcm2 phospho-Ser-41 and Mcm2 phospho-Ser-53 (Bethyl Laboratories, 
Montgomery, TX), ASK (Eurogentec, Seraing, Belgium), Mcm7 (Thermo Fisher Scientific, 
Fremont, CA), NDRG1 (Abcam, Cambridge, UK),  PCNA (Santa Cruz, CA), ribosomal 
protein S6, GPX1 and FTH1 (New England Biolabs, Herts, UK) and p16 and β-actin (Sigma, 
Gillingham, UK). 
 
For comparative SILAC analysis, “heavy” and “light” whole cell lysates were combined in a 
1:1 ratio based on protein concentration (30 g each) and separated by SDS-PAGE under 
reducing conditions.  Proteins were visualized by silver-staining (ProteoSilver Plus, Sigma 
Aldrich, Poole, UK), equally sized bands were excised from the gel lane and processed with 
the Progest Investigator (Digilab, Huntingdon, UK) using established protocols for reduction 
and alkylation 21.  Finally, gel plugs were rehydrated in 20 g/ml sequencing grade modified 
trypsin (Promega, Southampton, UK) and incubated overnight at 37°C.  Tryptic peptides 
were eluted, vacuum-dried, resuspended in 0.1% formic acid and analysed by LC-MS/MS.   
 
Mass Spectrometry 
LC-MS/MS was performed with an LTQ-Orbitrap Classic mass spectrometer (Thermo Fisher 
Scientific, UK).  Peptide samples were loaded using a Surveyor MS Pump and Micro AS 
autosampler (Thermo Fisher Scientific, UK) onto a MiChrom C18 CapTrap for desalting and 
then introduced into the MS via a nano-electrospray ion source consisting of a fused silica 
capillary column (I.D. 100 m; O.D. 360 m; length 20 cm; 5 m C18 Reprosil, Nikkyo 
Technos Co., Japan).  Separation was achieved by a dual gradient, formed of 5 - 23% Buffer 
B for 65 min, followed by 23% - 40% Buffer B for 30 min, and a step gradient to 60% Buffer 
B for 5 min (Buffer A = 0.1% formic acid; Buffer B = 100% acetonitrile (ACN), 0.1% formic 
acid).  The pump rate was reduced via a splitter to 0.9 l/min.  Measurements were 
performed in the positive ion mode.  The full scan precursor MS spectra (450 – 1600 m/z) 
were acquired in the Orbitrap analyzer with a resolution of r = 60,000.  This was followed by 
data dependent MS/MS fragmentation in centroid mode of the most intense ion from the 
survey scan using collision induced dissociation (CID) in the linear ion trap (normalized 
collision energy 35%, activation Q 0.25; electrospray voltage 1.4 kV; capillary temperature 
200°C; isolation width 2.00).  This MS/MS scan event was repeated for the top 6 peaks in the 
MS survey scan.  Target ions already selected for MS/MS were dynamically excluded for 40 
sec.  Singly charged ions were excluded from MS/MS analysis.  XCalibur software version 
2.0.7 (Thermo Fisher Scientific, UK) was used for data acquisition. 
 
Protein Identification and Quantification 
Raw MS files from all replicate SILAC experiments were uploaded onto the MaxQuant 
software platform (version 1.0.13.13) for peaklist generation, quantification of SILAC pairs, 
identification of individual peptides and assembly into protein groups 22, 23.  XCalibur raw files 
were processed by Quant.exe and Identify.exe of the MaxQuant suite, in combination with 
the Mascot search engine (version 2.2, Matrix Science, UK), and searched against a 
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concatenated International Protein Index (IPI) human protein database (version 3.54; 
containing 75,710 entries which includes 262 commonly observed contaminants such as 
porcine trypsin and some human keratins).  This decoy database also contained reversed 
versions of all sequences and was created with the Sequence Reverser programme within 
MaxQuant. Selected MaxQuant analysis parameters included: trypsin enzyme specificity, 
SILAC doublet measurements of Lys6 and Arg10, 2 missed cleavages, minimum peptide 
length of 6 amino acids, minimum of 2 peptides (1 of which is unique), top 6 MS/MS peaks 
per 100 Da, peptide mass tolerance of 7 ppm for precursor ions and MS/MS tolerance of 0.5 
Da.  Oxidation of methionine and N-terminal protein acetylation were selected as variable 
modifications and cysteine carbamidomethylation was selected as a fixed modification.  All 
proteins were filtered according to a false discovery rate (FDR) of 1% applied at both peptide 
and protein levels.  Proteins were automatically quantified in the MaxQuant software: a 
minimum of 3 peptide ratio counts from razor and unique peptides were necessary for 
protein quantification and the ‘requantification’ option was enabled 22, 23.  An Experimental 
Design template was used to specify individual experiments and reverse labelling conditions 
within the analysis.  In the final results files, all Protein Groups with a normalized ratio 
significance B score of ≤ 0.05 were accepted for down-stream analysis.   
 
Bioinformatics Analysis 
For the visualization and assignment of statistically overrepresented functional annotations, 
Ingenuity Pathway Analysis (IPA; version 8.0) 24, STRING (version 8.2) 25 and Cytoscape 
(version 2.6.3) 26 software were used.  REFSEQ protein identifiers and expression fold 
changes were uploaded into IPA and only direct interactions between molecules were 
selected for consideration by the IPA library.  A Fisher’s exact test identified canonical 
pathways most significant to the dataset.  The open-source STRING database was used for 
evaluation of protein-protein interaction partners within the dataset 25.  A list of all altered 
proteins were uploaded into STRING using HUGO Gene identifiers as input with a 0.7 
Confidence Score cut-off (high confidence).  A protein association network was created 
where molecules are represented as nodes connected via edges which represent the 
supporting evidence.  Cytoscape is an open-source software environment which provides a 
broad framework for biological data, where molecules are shown as nodes connected by 
edges which represent data attributes such as protein interactions.  Cytoscape can be 
extended to incorporate many additional plug-in modules such as the BiNGO tool for Gene 
Ontology (GO) enrichment analysis 27 or the MCODE algorithm for identification of densely 
connected protein clusters based on a graph theoretic clustering algorithm 28.  MCODE 
(version 1.3) was used to identify densely interconnected regions within the STRING protein 
network.  To assess overrepresentation of GO annotations, HUGO gene identifiers were 
uploaded into BiNGO (version 2.3) and a hypergeometric test was chosen with the 
Benjamini Hochberg FDR correction for multiple testing (significance level 0.05).  The three 
GO vocabularies were searched separately; namely Biological Processes (GOBP), Cellular 
Component (GOCC) and Molecular Function (GOMF) 29.  GO terms are represented as 
nodes and are linked in a hierarchical layout, where the size of each node is proportional to 
the number of molecules within the term and nodes are coloured by significance of 
enrichment of each term relative to the whole annotation. 
 
Results  
A subset of cellular proteins is affected by suppression of Cdc7 kinase.  
The general experimental approach and tools used in this study are outlined in Figure 1.  
The specificity of Cdc7 siRNA, the possibility of off-target effects as well as rigorous 
experimental validation of the Cdc7-depleted system, have all been previously addressed by 
our group 12, 14, 15 and evidence for the efficiency of the Cdc7 knockdown is summarized in 
Figure 2.  Transfection of IMR90 fibroblasts with Cdc7-siRNA (CDC7KD) reduced Cdc7 
mRNA levels by 80% relative to control-siRNA (CO) at 72 hr and Cdc7 protein levels were 
undetectable at this timepoint (Figure 2a).  Protein levels of the Cdc7 regulatory subunit ASK 
(activator of S-phase kinase) were also substantially reduced.  A reduction in total protein 
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level and loss of phosphorylation at Ser-41 and Ser-53 was observed for the major Cdc7 
substrate Mcm2 (Figure 2a and 2e).  A shift to hypo-phosphorylated Mcm2 has been 
previously documented following Cdc7 depletion 11, 12.  Growth of Cdc7-depleted cells 
reached a plateau 48 hr post-transfection, indicating cessation of cell proliferation (Figure 
2d) and the majority of these arrested cells accumulated with G1 DNA content (87%) (Figure 
2b).  The percentage of BrdU-incorporating cells dropped from 23% in CO cells to 3% in 
CDC7KD cells (Figure 2c), providing further evidence that Cdc7 depletion led to a G1 
arrested state.  A rescue experiment was performed by the expression of a CDC7 gene 
variant containing silent mutations in the siRNA targeting region.  This led to a recovery from 
cell cycle arrest, as demonstrated by re-expression of Cdc7 protein, phosphorylation of 
Mcm2 at Ser-41 and Ser-53, and increased BrdU incorporation (Figure 2e and 2f).   
 
Three biological replicates were performed for SILAC analysis of Cdc7-depleted versus 
control siRNA transfected cells.  A linear regression comparison of protein ratios for each 
biological replicate demonstrate the reproducibility of the replicates and is shown in 
Supplementary Figure S1 (Biological Replicate One versus Two: r2 = 0.7385; Biological 
Replicate One versus Three: r2 = 0.8142; Biological Replicate Two versus Three: r2 = 
0.8589).  In total, 338 individual SDS-PAGE gel slices from eight technical gel experiments 
were subjected to MS/MS analysis, resulting in 234,086 SILAC peptide pairs, of which 66% 
were sequenced (Table 1).  Using an FDR of 1% at the protein and peptide level, 2,452 
proteins were identified of which 2,045 were assigned quantitative abundance ratios based 
on a minimum of at least three abundance ratios for razor peptides (Table 1).  Plotting the 
normalized (Cdc7-depleted / control) ratio values for all 2,045 quantified proteins 
demonstrated that the spread of the entire dataset follows a Gaussian distribution and shows 
that the majority of cellular proteins are unaffected by Cdc7 knockdown (Figure 3a). Protein 
ratios were grouped into intensity bins of similar magnitude (each bin containing at least 300 
proteins) and evaluated as being differentially expressed based on the deviance of outlier 
ratios from the normalized distribution of all ratios (Significance B) 22, 23.  Plotting the protein 
intensities versus the protein ratios (Figure 3b) showed that across all intensity ranges, 
significant ratio outliers (coloured by Significance B values) are clearly distinct from the 
normalized ratio distribution.  315 quantified proteins were found to have a Significance B 
score of ≤ 0.05 and were taken to be significantly altered in expression.  The SILAC ratios of 
several of these proteins were verified by Western blotting (Supplementary Figure S2).  
Supplementary Table S1 contains relevant protein and individual peptide information for 
each of the 315 differentially expressed proteins.  These proteins were further evaluated by 
downstream applications to detect cellular functional attributes that are affected following 
impairment of replication origin activation.  Supplementary Table S2 contains identification 
and quantification information relating to the 1,730 unchanged proteins (Significance B > 
0.06).   
 
Cdc7 knockdown induces a metabolic and oxidative-stress response.  
The complete dataset of 2,045 quantified proteins was uploaded into IPA and an expression 
value cut-off of Significance B ≤ 0.05 was applied, allowing us to distinguish between altered 
and unaltered proteins in the analysis.  Of the 315 proteins with Significance B ≤ 0.05, IPA 
identified 270 function/pathway eligible molecules, while 45 proteins did not correspond to a 
functional annotation in the IPA knowledge base.  The successful molecules were mapped 
onto defined canonical pathways and ranked according to significance of association with 
the dataset.  The ten top scoring IPA canonical pathways are listed in Table 2, the mapped 
proteins are overlaid onto each pathway in Supplementary Figures S3- S12, and details 
regarding all mapped proteins for each pathway are given in Supplementary Table S3.   
 
“Nrf2-mediated oxidative stress response” was the most significantly affected pathway 
containing 18 differentially expressed proteins (Table 2).  Supplementary Figure S3 clearly 
demonstrates that they are mainly associated with the “reduction in oxidative damage” and 
activation of “phase I and II metabolizing enzymes” branches of the pathway.  A further 36 
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unchanged proteins were mapped downstream of Nrf2, indicating that a full-blown stress 
response was not initiated.  The “Glutathione Metabolism” pathway was also identified as 
significantly altered, containing six up-regulated proteins (26% of molecules mapped to 
pathway), and provides further evidence for a mild antioxidant stress response 
(Supplementary Figure S11).   
  
The other top-scoring pathways identified by IPA together indicate altered cellular 
metabolism and four major themes are apparent: fatty acid metabolism (“Synthesis and 
Degradation of Ketone Bodies”, “Butanoate Metabolism” and “Propanoate Metabolism”), 
steroid metabolism (“Biosynthesis of Steroids” and “Bile Acid Biosynthesis”), branched chain 
amino acid metabolism (“Valine, Leucine and Isoleucine Degradation”) and mitochondrial 
redox metabolism (“Oxidative Phosphorylation”).  These metabolic processes are 
functionally interlinked and some proteins participate in multiple pathways.  For example, the 
mitochondrial trifunctional enzyme (HADHA and HADHB subunits) and the HMG-CoA 
synthase (HMGCS1), all of which were found to be up-regulated, are implicated in fatty acid 
metabolism, ketone body synthesis and branched-chain amino acid degradation.  Ketogenic 
reactions and the catabolism of branched chain amino acids (valine, leucine and isoleucine) 
provide an alternative source of energy during fasting or low glucose conditions.  HMG-CoA 
(synthesized by HMG-CoA synthase) is also a key intermediate in the synthesis of 
cholesterol, the major precursor for the synthesis of bile acids, steroid hormones and fat-
soluble vitamins.  A significant increase in eight enzymes involved in the cholesterol 
biosynthetic pathway was observed (ACAT1, HMGCS1, MVD, IDI1, FDPS, FDFT1, LSS and 
NSDHL).  Cdc7 depletion also led to up-regulation of the cholesterol binding proteins NPC1 
and NPC2 which facilitate the endosomal / lysosomal transport of cholesterol-containing 
lipoproteins 30.  
 
Cellular-wide functional changes following Cdc7 depletion can be categorized by GO 
annotation.  
To identify descriptive GO annotations, the up-regulated (145 proteins) and down-regulated 
(170 proteins) groups were analysed separately against each GO ontology.  The most 
significantly enriched annotations for each GO category are presented in Table 3, with the 
corresponding proteins for each enriched term listed in Supplementary Table S4.  An 
overview of enriched generic GOSlim terms is shown graphically in Figure 4, with the 
corresponding proteins for each enriched GOSlim term listed in Supplementary Table S5.  
The pattern of enriched GO terms differs considerably between the up- and down-regulated 
protein groups.  BiNGO analysis for the group of 170 down-regulated proteins strongly 
suggests that Cdc7 knockdown results in reduced cellular biosynthesis and proliferation.  
The statistically enriched GOMF and GOBP terms include DNA, RNA and protein binding; 
RNA (and mRNA) splicing, processing and metabolism; as well as nucleosome and 
chromatin assembly.  The dataset contains 36 down-regulated proteins associated with the 
GOBP term “nucleobase, nucleoside, nucleotide and nucleic acid metabolic process” 
(GO:0006139).  GO enrichment analysis for the group of 145 up-regulated proteins indicated 
that catabolic processes, oxidation reduction and lipid metabolism were the major biological 
processes enhanced following Cdc7 depletion.  The corresponding molecular functions 
include oxidoreductase activity, catalytic activity and acetyl-CoA transferase activity.  
Together, the enriched GO terms clearly demonstrate a reduction in the transcriptional and 
translational machinery of the cell as well as activation of energy regenerative and metabolic 
processes during cell cycle arrest triggered by the origin activation checkpoint. 
 
Protein association networks and interaction clusters.  
The STRING database was used to create a protein interaction network from the list of 315 
differentially expressed proteins.  175 nodes (proteins) were found to be interconnected by 
894 edges representing highly confident protein interactions.  The network was imported into 
Cytoscape and MCODE analysis was used to identify densely-connected cluster regions 
(scores greater than 4.0) (Figure 5).  BiNGO GOSlim analysis for each cluster identified the 
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following statistically enriched annotations: Cluster 1 “RNA binding”; Cluster 2 
“Proteinaceous extracellular matrix”; Cluster 3 “Ion transport”; Cluster 4 “Respiratory electron 
transport chain”; Cluster 5 “Lipid metabolic process” and Cluster 6 “Nucleoplasm” (Figure 5).   
 
The extracellular matrix and calcium signalling are strongly affected by the origin activation 
checkpoint.  
Of the top ranking 15 proteins with the most significantly changed abundance ratios, seven 
were associated with the extracellular matrix or extracellular region/space (S100A7, BGN, 
DCN, HSPG2, HMOX1, DCD and GPC1) and four were associated with calcium ion binding 
(S100A9, CALML5, S100A8 and S100A7).  The S100 calcium binding proteins S100A9, 
S100A8 and S100A7 were up-regulated 16-fold, 17-fold and 15-fold respectively.  In total, 13 
significantly altered proteins were located to the extracellular matrix including five collagen 
isoforms (COL6A2, COL6A1, COL6A3, COL1A2 and COL4A2), and 21 proteins were 
involved in calcium ion binding (Figure 6a).  Coupled with the fact that changes occurred in 
32 cytoskeletal proteins (Figure 6a), it appears that modifications in intracellular architecture 
play a role in the response to checkpoint activation.  The present results indicate that very 
substantial changes occur at the cell surface of Cdc7-suppressed cells involving cell-cell 
adhesion and communication, suggesting that cell cycle-arrested fibroblasts may exhibit 
altered cellular exocytosis and may transmit growth-suppressing signals to their surrounding 
microenvironment and neighbouring cells. 
 
Cdc7 depletion induces a spatially-distributed response across different subcellular regions.  
GOCC analysis revealed a spatially-distributed response over specific subcellular regions.  
Depletion of Cdc7 resulted in the altered abundance of 34 mitochondrial proteins primarily 
involved in oxidative phosphorylation, antioxidant stress response and fatty acid oxidation 
(Figure 6b).  The data show increased abundance in five subunits of Complex I of the 
electron transport chain (NDUFA8, NDUFB7, NDUFS4, NDUFS2 and NDUFS1) which 
functions in the oxidation of NADH and establishes the electrochemical gradient necessary 
to drive ATP synthesis.  Up-regulation of the mitochondrial membrane protein NAD(P) 
transhydrogenase (NNT) was also found, which is involved in the respiratory chain 
production of NADPH, as well as up-regulation of the mitochondrial apoptosis-inducing factor 
(AIF) which in normal cells functions as an NADH oxidase flavoprotein involved in oxidative 
phosphorylation, redox control and maintenance of Complex I 31.  The mitochondrial 
hexokinase isoforms HK1 and HK2 bind to the outer mitochondrial membrane and maintain 
the opening of the mitochondrial pore, and were also increased in abundance.  These 
isoforms can redirect newly generated mitochondrial ATP to drive glycolytic pathways, in 
effect coupling glucose metabolism to oxidative phosphorylation 32-34.   
 
This study has identified significant changes in the abundance of 22 lysosomal proteins 
(Figure 6b), including up-regulation of the lysosomal membrane proteins LAMP1, LAMP2, 
CD63 and SCARB2/LIMP2.  The lysosomal degradation of proteins, nucleic acids, lipids and 
carbohydrates requires a variety of acid hydrolases which are active within the acidic intra-
lysosomal microenvironment.  The acidification of lysosomes and recycling endosomes is 
established by membrane proton pumps (ATPases), and five subunits of the V-type proton 
ATPase were up-regulated by Cdc7 depletion (ATP6V1C1, ATP6V1A, ATP6V1G1, 
ATP6V1B2, ATP6V1E1).  Several major lysosomal hydrolases and degradative enzymes 
were found to be altered in abundance, including cathepsins (CTSD, CTSB, CTSA), 
prosaposin (PSAP), and beta-hexosaminidase (HEXA, HEXB).  Several lysosomal-
associated trafficking molecules were also affected by Cdc7 depletion.  RAB7A is important 
for the fusion of autophagosomes with lysosomes and has recently been found to complex 
with the novel FYCO1 protein for promotion of microtubule-directed transport of autophagic 
vesicles 35.  Both RAB7A and FYCO1 were significantly up-regulated in abundance.  We 
found down-regulation of three subunits of a major heterotetrameric adapter protein AP-3 
(AP3M1, AP3S1 and AP3B1) that participates in receptor-mediated endocytosis.  Deficiency 
of endosome-localized AP-3 is known to result in impaired sorting of the LAMP family of 
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lysosomal membrane proteins from the endosome to the lysosome, resulting in the 
increased redistribution of LAMPs to the plasma membrane 36.  Therefore, the up-regulation 
of lysosomal membrane glycoproteins presented here could reflect altered endosomal 
trafficking as a consequence of diminished AP-3 levels.   
 
The heterogeneous nuclear ribonucleoprotein (hnRNP) complex was identified as the most 
significantly enriched GOCC annotation for the group of down-regulated proteins (Table 3).  
The hnRNPs are a family of RNA binding proteins that associate with nascent mRNA 
transcripts in the nucleus and influence mRNA metabolism, stability, splicing, processing and 
nucleocytoplasmic transport 37.  RNA binding proteins such as hnRNPs maintain genomic 
stability and link nuclear mRNA transcriptional events with protein translation in the 
cytoplasm.  Eight individual hnRNPs were found to be significantly reduced in expression in 
our dataset (HNRNPA1, HNRNPA0, HNRNPH3, HNRNPA2B1, HNRNPH1, HNRPDL, RALY 
and RBMX), as well as five other RNA binding proteins involved in gene regulation (RBM14, 
RBM3, RBMS2, CIRBP and KHDRBS1), further supporting the argument for reduced mRNA 
biogenesis, splicing and stability in the cell cycle arrested fibroblasts.     
 
Depletion of Cdc7 leads to reduced proliferative capacity of the cell. 
A reduction in key components of the DNA replication machinery was observed following 
Cdc7 depletion (Figure 7).  The suppression of Cdc7 resulted in down-regulation of two 
subunits of its major substrate, the MCM2-7 helicase (MCM2 and MCM7).  Cdc7 depletion 
also resulted in reduced levels of the proliferating cell nuclear antigen (PCNA) which is a 
cofactor for DNA polymerases 38 and also a reduction in FEN1, an endonuclease involved in 
synthesis of the lagging DNA strand.  Seven histone proteins were decreased in abundance 
(HIST1H1C, HIST1H1B, H2AFZ, HIST2H3PS2, HIST1H2BN, HIST3H2BB and H1F0) while 
one core histone H2AFY2 protein was increased.  There was also a reduction in nuclear 
autoantigenic sperm protein (NASP) which acts as a H1 linker histone chaperone and is 
involved in nuclear transport of H1 histones and chromatin assembly on newly synthesised 
DNA 39.  Altered abundance of two cyclin-dependent kinases (CDK4 and CDC2/CDK1) was 
detected as well as a six-fold elevation in a cyclin-dependent kinase inhibitor CDKN2A.  
Together, these results suggest that many elements of the DNA replication machinery are 
altered when Cdc7 is removed from the cellular environment.   
 
Cell cycle arrest can be accompanied by reduced ribosomal biogenesis and mRNA stability 
40.  Protein translation initiation is a multistage process involving several translation factors 
which facilitate the recruitment of the ribosome to the mRNA.  Eukaryotic initiation factors 
are known to be inactivated during starvation or stressful conditions to reduce translation of 
many mRNAs 41.  Three eukaryotic translation initiation factors (EIF4H, EIF4G1 and EIF3A) 
and eight different ribosomal proteins (RPL23A, RPS10, RPS6, RPL27A, RPL36AL, RPL19, 
RPL10 and RPL5) were decreased in abundance (Figure 7).  In addition to the reduction in 
hnRNPs and the RNA binding proteins mentioned above, several other DNA, RNA and 
nucleotide processing molecules were also significantly reduced in abundance following 
Cdc7 depletion, including YBX1, THOC4, PABPN1, CPSF7, DDX5 and RRM2 (Figure 7).    
 
Discussion 
The existence of an origin activation checkpoint which monitors DNA replication initiation has 
recently been demonstrated in human somatic cells 1, 11, 12, 15.  In the study presented here, 
RNAi against Cdc7 in human fibroblasts was coupled with a high resolution, quantitative 
proteomics and bioinformatics strategy for evaluation of the global response involved in the 
maintenance of cell cycle arrest at this checkpoint.  In the following, we first discuss the clear 
evidence that this checkpoint is an actively maintained cellular state, that Cdc7 depletion 
triggers a multitude of diverse cellular responses at varying subcellular locations and that 
perturbation of DNA replication initiation results in reduced proliferative capacity.  
Subsequently, we compare the Cdc7 depletion-induced cell cycle arrest to G0, noting that 
the cellular response strongly resembles a quiescence-like state.  Finally, we note current 
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limitations on global proteomic measurements and suggest that complementary, directed 
proteomics experiments aimed at characterizing spatial/temporal features should provide a 
more complete analysis of the nature of the apparent quiescence-like state induced by Cdc7 
depletion.  
 
It is now well accepted that redox-dependent signalling pathways are intrinsically linked to 
cell cycle progression 42.  It is therefore not surprising that key antioxidant molecules were 
found to be increased in abundance during activation of the Cdc7 checkpoint, suggesting a 
coordinated response to mild oxidative stress.  In particular, the effector molecules of the 
“Nrf2-mediated oxidative stress response” pathway were highlighted by IPA analysis.  Nrf2 is 
a key cytoprotective transcription factor which undergoes nuclear stabilization in response to 
elevated levels of oxidative or electrophilic species 43.  It induces the transcription of a 
battery of antioxidant and detoxifying genes containing antioxidant response elements 
(ARE), which are responsible for eliminating oxidative species and restoring redox 
homeostasis 43-45.  Cdc7 depletion resulted in up-regulation of the two major thiol-containing 
redox systems, thioredoxin and glutathione, both of which are under the transcriptional 
regulation of Nrf2.  Our results demonstrate a six-fold increase in abundance of heme 
oxygenase (HMOX1) which is an ARE-containing sensor of cellular stress and inflammatory 
insult.  A three-fold increase was found in the iron-sequestering molecule ferritin (FTH1 and 
FTL) and several xenobiotic metabolizing enzymes were also up-regulated, such as the 
multidrug-resistance associated protein ABCC1, the biotransformation enzyme epoxide 
hydrolase (EPHX1) and AKR1C1 a member of the aldo-keto reductase family of soluble 
NAD(P)H oxidoreductases.  We also found elevated levels of sequestosome (SQSTM1), a 
protein recently shown to exert its pro-survival role by activating a variety of ARE-containing 
genes 46.  However, many proteins downstream of Nrf2, including several classical 
antioxidant molecules (peroxiredoxins and superoxide dismutases) remained unchanged in 
abundance.  This reinforces the premise that the arrested cells show a stimulus-specific 
response, are responding to mild levels of stress, and do not require activation of the full 
complement of stress response proteins.  This implicitly suggests that other factors may 
modulate pathway(s) involving Nrf2 and activation of ARE.  
 
The cytoprotective Nrf2 transcriptional programme is also known to be induced during a 
condition known as stress hormesis; a beneficial cellular preconditioning mechanism 
whereby exposure to mild stress promotes the expression of antioxidant enzymes and 
enables the cell to withstand future stresses, such as higher doses of the same stress-
inducing agent or general cytotoxic stressors 47, 48.  It is therefore likely that the antioxidants, 
detoxifying enzymes, heat-shock chaperones and growth factor-induced molecules that were 
found to be altered in Cdc7-depleted cells, actually represent a self-preservation hormetic 
response to mild stress levels.  This observation strongly supports an active role for Cdc7 
depletion in stable, viable and reversible G1 arrest.   
 
Non-proliferating cells held in cell cycle arrest are thought to have lowered metabolic 
requirements and reduced energy flux.  Therefore, it was surprising to discover that Cdc7 
depleted cells exhibit increased demand for energy obtained from the breakdown of fats and 
proteins.  Catabolic processes such as lysosomal proteolysis, fatty acid beta-oxidation, 
synthesis / degradation of ketone bodies and branched-chain amino acid degradation were 
all overrepresented in this analysis.  These energy-liberating pathways are most commonly 
utilized during fasting conditions, and it has long been known that serum deprivation can 
induce quiescence 18.  The Cdc7 depleted cells however, are maintained in complete media 
and receive full nutrients, suggesting that they become more self-reliant in terms of energy 
generation and less dependent on external energy resources.  Additionally, we observed 
down-regulation of the serum-deprivation response factor (SDPR) and unchanged levels of 
autophagy-related proteins (ATG3 and ATG4B), all of which would typically be up-regulated 
during serum starvation 49, 50.  Therefore, we propose that the Cdc7 depleted proteome either 
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mimics calorie restriction to drive cell cycle arrest, or that calorie restriction and Cdc7 
deprivation share common, but not identical, afferent regulators of quiescence.   
 
In addition to the metabolic, structural and protective responses implicated in the 
maintenance of the arrested state, we have also observed changes in a subset of proteins 
responsible for the characteristic suppression of growth and proliferation during cell cycle 
arrest.  Down-regulation of a range of proteins involved in DNA replication, RNA 
transcriptional events and protein translation all support a reduction in protein biosynthetic 
efficiency and reduced proliferative capacity in Cdc7 depleted cells.  Furthermore, proteins 
specifically involved in amino acid biogenesis were found to be down-regulated.  For 
example, an asparagine biosynthetic enzyme (ASNS) was reduced, as were all three 
enzymes involved in the three-step serine biosynthesis pathway (PHGDH, PSAT1 and 
PSPH).  We have also observed altered expression of other proteins implicated in growth 
inhibition and reduced proliferation.  The tumour metastasis suppressor protein, N-Myc 
downstream-regulated gene 1 (NDRG1), was increased in abundance.  Although the 
function of NDRG1 is still unclear, this pleiotropic molecule is known to have tumour 
suppressing qualities which inhibit cancer cell growth and metastasis by modulating many 
cellular processes including differentiation, proliferation and invasion 51-53.  Over-expression 
of NDRG1 in a prostate cancer model led to a reduction in adhesion, decreased proliferation 
and reduced structural components of the ribosome 51.  A recent proteomics study revealed 
that a large number of ribosomal, protein translation and RNA processing proteins are found 
within the NDRG1 interactome 54.  NDRG1 is a stress-responsive transcriptional target of 
p53 55 and was one of a panel of p53 target genes which were specifically up-regulated by 
oxidative stress 56.  Dong et al demonstrated that NDRG1 is up-regulated during mimosine-
induced cell cycle arrest at late G1 phase and they suggest that NDRG1 may be an 
important factor in G1 arrest 57.   
 
It is clear from the present results that impairment of DNA replication origin activation is not 
limited to processes taking place exclusively in the nucleus.  Although subcellular location 
annotations for proteins are still sparse 58, evidence was obtained that the arrested state is 
coupled to a diverse range of other processes that are predominantly located in 
mitochondria, lysosomes and the cell surface / extracellular region.  Not surprisingly, there 
are also strong indications of changes in protein trafficking.  The importin alpha/beta 
complex mediates the nuclear transportation of many proteins including Cdc7 via the nuclear 
pore complex 59 and the reduced abundance of importin-alpha-2 (KPNA2) suggests 
disturbances in nucleocytoplasmic transport.  Changes in abundance of transport molecules 
such as the lysosomal / endosomal trafficking proteins, the Rab GTP-binding proteins 
(RAB7A, RAB3A and RAB21) and chaperone proteins (DNAJB6, DNAJB1, DNAJC8, 
DNAJB4, DNAJC10 and DNAJC9) all imply that dynamic protein trafficking between spatially 
separated compartments is affected during maintenance of the arrested state.   
 
Together, these results paint a picture of a metabolically active cell utilizing its own 
resources and energy stores to enhance survival and sustain its existence.  It would appear 
that the origin activation checkpoint at late G1 phase in human fibroblasts is maintained by 
activation and repression of biological processes which have previously been linked to 
maintenance of cellular quiescence.  In support of this, we have also seen increased 
abundance of specific molecules which are known to become activated during G0, for 
example the small leucine-rich proteoglycan decorin (DCN) was up-regulated 8-fold and is 
one of a small group of “quiescins” whose expression is elevated during quiescence in 
human lung fibroblasts 60 and myogenic cells 61. 
 
To what extent are the changes observed for Cdc7 depleted cells synonymous with 
quiescence?  Quiescence is generally accepted to be a reversible “out-of-cycle” state where 
cells withdraw from the cell cycle into a non-dividing state, in which they survive until 
mitogenic stimuli persuade them to resume proliferation 62.  Despite the fact that the majority 
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of eukaryotic cells exist in this non-proliferating state, the cellular control of quiescence is still 
poorly understood.  The traditional view is that quiescent cells reduce their proliferative 
potential, lower their metabolic output and exist in an extended G1 or resting phase outside 
of the cell cycle.  We and others have previously shown that loss of proliferative capacity in 
G0 is accompanied by down-regulation of replication licensing factors and the licensing 
repressor geminin 20, 63.  This led to a new definition of G0 as a “reversible withdrawal from 
the cell cycle characterized by unlicensed origins and the absence of CDK activity” 64.  More 
recently, there is growing evidence that quiescence is under active transcriptional control 
and involves a dynamic, coordinated response throughout the cell. 
 
Transcriptomic studies in yeast and mammalian cells have begun to address the role of 
candidate quiescence factors in the induction and maintenance of the G0 state, although as 
yet there are no equivalent large-scale proteomic analyses.  The fission yeast S. pombe G0 
transcriptome has been investigated using nitrogen starvation-induced quiescence 65.  A 
diverse group of gene transcripts were found to be important for maintenance of the G0 state 
and were implicated in processes such as amine catabolism, oxidoreductase and hydrolase 
activity, carbohydrate metabolism, autophagy, mitochondrial ATPase function, ubiquitin-
dependent proteolysis, cytoskeletal networks and cell communication.  The S. pombe model 
was also used to identify 33 core genes required for entry into and maintenance of 
quiescence 66.  These genes encoded proteins involved in broad ranging processes such as 
stress-response, cell cycle kinase activity, chromatin remodelling, RNA splicing, ribosomal 
biogenesis, translation, lipid and ATP metabolism, protein trafficking, enodosome formation 
and vesicle fusion.  Many of these genes have human homologs and it is thought that the 
genetic profile induced by quiescence may be conserved from yeast to higher eukaryotes 67.     
 
The interpretation of yeast G0 as a dynamic state correlates well with studies of human 
quiescence.  Venezia et al observed that principally quiescent adult hematopoietic stem cells 
exist in a “state of readiness” to react to environmental changes 68.  Two recent studies used 
gene expression profiling to demonstrate the existence of a transcriptional panel necessary 
for the regulation of cellular quiescence in human fibroblasts 18, 69.  Coller et al identified that 
fibroblast quiescence is actually a dynamic collection of states with a shared “quiescence 
programme” of genes required for general enforcement of the G0 phenotype 18.  This 
programme included genes important for ensuring the reversibility of the G0 state, 
intercellular communication, suppression of growth, division and terminal differentiation as 
well as anti-apoptotic genes.  Liu et al identified a distinct set of serum deprivation early 
response genes necessary for induction, rather than maintenance of quiescence and found 
that these genes were implicated in immune responses, redox reactions and extracellular 
matrix metabolism 69.  The various genome-wide studies of cellular quiescence mentioned 
here are all in agreement that G0 is a highly dynamic and active state regulated across 
many subcellular regions, and there is increasing evidence that different forms of quiescence 
are induced by different stimuli 18.  Therefore, quiescence should no longer be regarded as a 
passive, resting state for cells in the absence of mitogenic stimuli, and instead should be 
thought of as an umbrella term for an actively maintained, reversible cellular arrest.  
 
Can proteomics tell us more about the exact nature of the “poised quiescence” state induced 
by Cdc7 depletion?  Generally speaking, the analysis of biological function from large scale 
transcriptomic and proteomic datasets is still evolving.  A number of different approaches, 
software and knowledge-bases are now available, each of which tends to have its own 
strengths and weaknesses.  IPA has been extensively used in recent years to analyze large 
scale “omics” datasets (2781 scientific publications citing the use of IPA, as of June 2010) 24.  
Recently, the combination of STRING and MCODE for identification of enriched clusters 
within protein networks has been successfully applied in several studies, including a lysine 
acetylation network 70 and a DNA damage response network 71.  In the present case, the IPA 
pathway tool and the BiNGO GO term enrichment analysis identified complementary 
biological processes affected by Cdc7 depletion.  The strategy of applying several different 
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data-mining tools to the analysis seems to be essential at the present stage of development 
and greatly improved our ability to extract statistically significant and functionally intelligible 
information from the large-scale proteomic dataset.  Even so, an interesting feature of the 
present results was that the IPA / STRING data-mining methods did not classify some of the 
largest changes in abundance ratios to strongly connected networks and largely missed 
highly significant changes at the cell surface and extracellular space.  Data-mining methods 
such as IPA and STRING emphasize well-documented biology by providing dense networks 
of previously established knowledge and may neglect more ambiguous proteins and 
processes.  While this provides a very useful overview, less well-studied biological systems 
may be poorly detected or defined by these data-mining methods.  The existence of “orphan” 
proteins with large, highly significant changes in abundance may provide priorities for further 
investigations aimed at defining “new” biological cellular responses.  
 
The observation that global response patterns of the type analyzed here seem to show 
features and groups of proteins specific to the stimulus opens the way to further unravelling 
very complex cellular networks.  As we have noted elsewhere 58, 72, the key to this may be 
more explicit measurement of the spatio/temporal fluxes of proteins.  The existence and 
preservation of differentiated subcellular structures, as well as the communication links 
between them ensure that functional processes are spatially and temporally distributed 
across many subcellular locations, and this is clearly the case for Cdc7 regulation.  The 
present study is limited temporally in that depletion of Cdc7 by RNAi is a slow process and 
some of the subcellular responses observed may represent long term adaptation of the cells 
to a “lesion”.  This technical limitation makes it difficult to ascertain whether the observed 
biological changes are a cause or consequence of triggering the origin activation checkpoint.  
There is still a need for more rapid, dynamic methods of specifically perturbing cellular 
function, and the recent development of Cdc7 inhibitors will allow modulation of Cdc7 
function, so that subsequent dynamic effects can be followed as a function of time.  
Similarly, there are currently restrictions on the spatial interpretation of the proteomics 
results.  One of the weak points in current database annotations is that subcellular location 
and function are generally not coupled.  All but four of the proteins showing changed 
abundance ratios were annotated with multiple locations (33 proteins had no associated 
GOCC term) and many proteins may have functional / regulatory annotations which are 
probably inconsistent with a single subcellular location.  
 
Global proteomics measurements still have limited proteome coverage that may constrain 
deciphering of the contributions of different systems to cellular response.  For example, we 
recently identified FOXO3a as a major player for the co-ordination of the origin activation 
checkpoint 15.  The FOXO pathway is known to powerfully tip the balance of the cell towards 
quiescence 73, and FOXO and Nrf2 are both hormesis-inducing, oxidative stress-responsive 
pathways 47, 74.  However, the present results do not elucidate to what extent the FOXO and 
Nrf2 pathways may be parallel, competing or cooperative pathways and/or the extent to 
which interpretation of the global proteomics data may be conditioned by previous research 
priorities encoded in existent databases.  With the above noted spatio/temporal constraints 
in mind, we have begun complementing the present experiments with further data on nuclear 
proteins, especially in networks under control by phosphorylation. 
 
Finally, our results should be interpreted in the context of emerging Cdc7-targeted therapies.  
Targeting Cdc7 has been shown to induce potent cancer-cell-killing in a broad range of 
tumour types as a result of an abortive S phase followed by apoptotic cell death.  Here we 
have shown that primary somatic cells circumvent lethal S phase progression under similar 
Cdc7 rate-limiting condition by engaging an origin activation checkpoint and undergoing a 
robust G0/G1 cell cycle arrest.  We have shown that viability and maintenance of this 
arrested state involves modulation of the cellular metabolic signature, initiating a dynamic 
quiescence-like response, and priming cells for cell cycle re-entry.  It now remains to be 
seen whether Cdc7 inhibitors in healthy tissues, particularly self-renewing tissues 
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characterized by high turnover (e.g. bone marrow and gut mucosa), also induce a protective 
quiescence-like arrest.  If this is the case then we might expect to observe low toxicity with 
such anti-cancer agents.   The ability to analyse large-scale, systems-wide datasets by 
proteomics methods is now becoming routine and we believe that further elucidation of origin 
activation checkpoint networks will provide ways to go beyond single target “magic bullet” 
approaches to cancer therapy.   
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FIGURE LEGENDS 
Figure 1:  SILAC workflow.  A combined strategy involving RNAi against Cdc7, SDS-PAGE 
protein fractionation, LC-MS/MS data acquisition with a LTQ-Orbitrap (Thermo Fisher 
Scientific) and downstream bioinformatics for identification, quantification and functional 
annotation was applied in this study. 
 
Figure 2: Cdc7 depletion arrests IMR90 fibroblasts in G1 phase of the cell cycle.  (a)  
Immunoblot analysis for Cdc7, its regulatory subunit ASK, and its substrate Mcm2 in control-
siRNA (CO) and Cdc7-siRNA transfected (CDC7KD) IMR90 whole cell extracts (actin loading 
control). (b) DNA content of CO and CDC7KD cells was assessed by FACS analysis. 
Percentages of cells found to be in G1, S and G2 phases of the cell cycle are indicated. (c) 
CO and CDC7KD cells were stained for BrdU incorporation and DNA was counterstained with 
propidium iodide (PI).  Percentages of BrdU-incorporating cells are indicated. (d) Cell 
number was measured at the indicated time-points (UT, untreated control). (e) Immunoblot 
analysis of Cdc7 protein levels and phosphorylation of Mcm2 at Ser-41 and at Ser-53 in 
cytoplasmic fraction (CF) and nuclear extract (NE) (actin and Orc4 loading controls). 
“Rescue” indicates IMR90 cells transfected with a CDC7 rescue plasmid. (f) Cells were 
measured for BrdU incorporation in CO, CDC7KD transfected cells, as well as CDC7KD cells 
treated with CDC7 rescue plasmid.  Light blue indicates BrdU-incorporating cells and dark 
blue indicates DAPI-stained nuclei. 
 
Figure 3:  Overview of the distribution of abundances for the entire SILAC dataset.  (a) The 
spread of normalized (log) protein abundance ratios expressed as a histogram follows a 
normal distribution.  (b) Normalized protein abundance ratios plotted against protein 
intensity.  Individual proteins are coloured by their significance B (Sig B) value.  Green: 
proteins with no detected change in abundance (1,601 proteins; Sig B: 0.1 - 0.5); Yellow: 
proteins with small, non-significant changes in abundance (129 proteins; Sig B: 0.06 - 0.1); 
Red: proteins with moderately significant abundance changes (181 proteins; Sig B: 0.01 - 
0.05); Blue: proteins with highly significant abundance changes (134 proteins; Sig B < 0.01).   
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Figure 4:  GOSlim functional annotation enrichment for up and down-regulated protein 
groups.  Enrichment of GOSlim annotations was computed using BiNGO for up- and down- 
regulated protein groups separately (145 up-regulated proteins; 170 down-regulated 
proteins).  Overrepresented terms are displayed graphically as hierarchical trees for each 
ontology (GOBP, GOMF and GOCC), where each term is shown as a node and parent-
daughter terms are connected by edges.  The size of the node is proportional to the number 
of molecules within this group and the colour of the node represents the significance of 
enrichment (see colour scale).  To distinguish up and down regulated processes, nodes 
linked by green edges are found only in the up-regulated group, whereas nodes linked by 
red edges are only found in the down-regulated group.  Nodes linked by black edges are 
common to both groups.  All proteins relating to each term and individual term significance 
scores are listed in Supplementary Table S5. 
 
Figure 5:  The Cdc7 depletion protein-protein network.  Network association analysis of 
altered proteins was created with STRING software and viewed in Cytoscape.  All 315 
significantly altered proteins were uploaded with an Interaction Confidence Score of ≥ 0.7, 
resulting in 175 nodes and 894 edges.  Nodes are coloured by fold change and are linked by 
edges which represent types of interaction evidence.  The top six MCODE clusters of 
densely interconnected regions are circled and labelled according to the most enriched 
GOSlim term for that cluster of proteins.  MCODE scores for each cluster, GO term 
identification number (GO-ID), annotation name, significance of GO term enrichment (corr p-
value) and number of molecules within each cluster which match the term (x) are shown in 
the table below.  Further information for each protein node can be found in Supplementary 
Table S1. 
 
Figure 6:  Large abundance changes were associated with extracellular matrix, calcium ion 
binding, cytoskeleton, mitochondria and lysosomes.  Shown are fold change expression 
values for proteins associated with the GOCC terms “extracellular matrix”, “cytoskeleton”, 
“mitochondria” and “lysosome” as well as the GOMF term “calcium ion binding”. 
 
Figure 7:  Cdc7 depletion is associated with reduced cellular proliferation.  Shown are fold 
change expression values for proteins associated with the KEGG pathway term “cell cycle”, 
the GOCC term “nucleosome”, and the GOBP terms “DNA replication”, “RNA splicing” and 
“translation” or “translational elongation”. 
 
Table 1:  Overview of MS results obtained with MaxQuant software.  Shown are the results 
obtained by MaxQuant (version 1.0.13.13) analysis of the Cdc7 depleted SILAC dataset 
using defined analysis parameters (outlined in the Experimental Procedures).  a Protein 
groups identified under MaxQuant search parameters with protein and peptide FDR = 1%.  b 
Protein abundance ratios are calculated as median values using a minimum of 3 quantifiable 
razor peptides. c Protein ratios with Significance B ≤ 0.05 were accepted as differentially 
expressed. 
 
Table 2:  IPA canonical pathways affected by Cdc7 suppression.  2,045 quantified proteins 
were uploaded into Ingenuity Pathway Analysis (IPA) software using REFSEQ identifiers, 
fold changes and Significance B p-values.  The expression value cut-off was set to 0.05.  
This resulted in 2,023 molecules being mapped to the Ingenuity knowledge base, of which 
270 qualified as function/pathway eligible molecules (molecules which meet the expression 
value criteria and have at least one functional annotation in the IPA knowledge base).  
Shown are the top ranking 10 canonical pathways associated with this dataset. A Benjamini-
Hochberg test was used to test for significance of the overrepresentation of each pathway 
(BH p-value).  A ratio value is given for the number of proteins identified within the pathway 
(No. mapped) divided by the total number of molecules for the pathway within the IPA library 
(Total available).  Another ratio is given for the number of significantly altered molecules (No. 
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differentially expressed) divided by the number of proteins identified in the pathway (No. 
mapped).  The differentially expressed proteins associated with each pathway are also 
listed.  All proteins mapped to these 10 pathways are detailed in Supplementary Table S3 
and proteins are overlaid onto each pathway in Supplementary Figures S3-S12. 
 
Table 3:  Gene Ontology term enrichment for protein sets with increased/decreased 
abundance.  Over representation of GO annotation terms for the separate sets of up and 
down-regulated proteins was computed using the BiNGO plug-in for Cytoscape.  Each GO 
category (GOBP, GOCC and GOMF) was processed separately.  Shown are the top scoring 
10 annotations for each category, with corresponding GO-ID reference number, number of 
proteins found to be associated with each term (x) and the Benjamini p-value indicating the 
significance of the enrichment.  All proteins found within each term are listed in 
Supplementary Table S4.    
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TABLE OF CONTENTS (TOC) SYNOPSIS 
An origin activation checkpoint has recently been discovered in the G1 phase of the mitotic 
cell cycle, which can be triggered by loss of DNA replication initiation factors such as the 
Cdc7 kinase.  We have used RNAi against Cdc7 in combination with SILAC-based high 
resolution MS proteomics to investigate the cellular mechanisms underlying the maintenance 
of the origin activation checkpoint.  Bioinformatics analysis identified changes in cellular 
energetic flux, moderate stress response, reduced proliferative capacity and a spatially-
distributed response across the mitochondria, lysosomes and the cell surface.  We propose 
that the Cdc7-depleted proteome maintains cellular arrest by initiating a dynamic 
quiescence-like response. 
 
 
    
